- Home
- CERT vs SVA Comparison
CERT vs SVA Comparison
Compare CERT & SVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CERT
- SVA
- Stock Information
- Founded
- CERT 2008
- SVA N/A
- Country
- CERT United States
- SVA
- Employees
- CERT N/A
- SVA 3261
- Industry
- CERT Retail: Computer Software & Peripheral Equipment
- SVA
- Sector
- CERT Technology
- SVA
- Exchange
- CERT Nasdaq
- SVA NYSE
- Market Cap
- CERT N/A
- SVA N/A
- IPO Year
- CERT 2020
- SVA N/A
- Fundamental
- Price
- CERT $14.15
- SVA $6.47
- Analyst Decision
- CERT Buy
- SVA
- Analyst Count
- CERT 6
- SVA 0
- Target Price
- CERT $15.00
- SVA N/A
- AVG Volume (30 Days)
- CERT 2.6M
- SVA N/A
- Earning Date
- CERT 05-05-2025
- SVA N/A
- Dividend Yield
- CERT N/A
- SVA N/A
- EPS Growth
- CERT N/A
- SVA N/A
- EPS
- CERT N/A
- SVA N/A
- Revenue
- CERT $385,148,000.00
- SVA N/A
- Revenue This Year
- CERT $11.42
- SVA N/A
- Revenue Next Year
- CERT $8.70
- SVA N/A
- P/E Ratio
- CERT N/A
- SVA N/A
- Revenue Growth
- CERT 8.70
- SVA N/A
- 52 Week Low
- CERT $8.64
- SVA N/A
- 52 Week High
- CERT $17.94
- SVA N/A
- Technical
- Relative Strength Index (RSI)
- CERT 69.51
- SVA N/A
- Support Level
- CERT $13.35
- SVA N/A
- Resistance Level
- CERT $14.49
- SVA N/A
- Average True Range (ATR)
- CERT 0.94
- SVA 0.00
- MACD
- CERT 0.58
- SVA 0.00
- Stochastic Oscillator
- CERT 94.27
- SVA 0.00
About SVA SINOVAC BIOTECH LTD
Sinovac Biotech Ltd is a China-based biopharmaceutical company that focuses on research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases including, without limitation, hepatitis A, hepatitis B, hand foot and mouth disease (HFMD) caused by EV71, seasonal influenza, H5N1 and H1N1 pandemic influenza, coronavirus, pneumococcus, poliomyelitis, varicella and mumps.